Autopsy report · NCT03820947
VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
Cause of deathSafety
“Follow-up of the VenaSeal vs. Endothermal Ablation and Venous Leg Ulcer studies was concluded early due to increased evidence of safety and effectiveness of VenaSeal in published literature and to reduce burden to investigators and sites.”
Life of this trial
- Registered 1 year 1 month before it started.
- Ran for about 5 years 9 months before it stopped.
- 506 participants enrolled.
- Results were posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Medtronic Endovascular
- Sponsor type
- Industry
- Conditions
- Venous Reflux
- Interventions
- VenaSeal™ System; Endothermal Ablation (ETA); Surgical Stripping
- Participants
- 506
- Sites
- 32
- Countries
- Australia, Canada, France, Germany, Italy, Netherlands, South Korea, Spain, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.